Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RADHIKA SHAH

Allopathic & Osteopathic Physicians Dermatology

NPI
1386105179
CMS profile
11458510
Location
NEWARK, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$54,083.08

200 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RADHIKA SHAH

NPI 1386105179 · CMS profile ID 11458510

Allopathic & Osteopathic Physicians / Dermatology

NEWARK, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386105179?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RADHIKA SHAH, NPI 1386105179, CMS profile ID 11458510. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386105179?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RADHIKA SHAH, NPI 1386105179, CMS profile ID 11458510. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386105179?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RADHIKA SHAH, NPI 1386105179, CMS profile ID 11458510, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1386105179?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

200 matching records · $54,083.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 200 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 200.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $18.2811/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175205396 CMS
LEO Pharma Inc. $120.2011/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035122 CMS
LEO Pharma Inc. $886.8111/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252035124 CMS
Incyte Corporation $7.2911/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226194288 CMS
LEO Pharma Inc. $2,850.0011/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035114 CMS
LEO Pharma Inc. $41.8611/06/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252035116 CMS
LEO Pharma Inc. $2,375.0011/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035118 CMS
LEO Pharma Inc. $1,425.0011/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035120 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $7.3311/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251047774 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $4.1311/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251047776 CMS
ABBVIE INC. $27.3711/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204194391 CMS
LEO Pharma Inc. $12.5411/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035112 CMS
Incyte Corporation $24.9910/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226188616 CMS
Janssen Biotech, Inc. $6.7510/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175205327 CMS
UCB, Inc. $0.8310/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224774136 CMS
UCB, Inc. $12.4210/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224774138 CMS
LEO Pharma Inc. $16.8110/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035110 CMS
Novartis Pharmaceuticals Corporation $19.5310/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200451513 CMS
LEO Pharma Inc. $578.0010/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252035108 CMS
ABBVIE INC. $51.0310/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204194385 CMS
Janssen Biotech, Inc. $13.6510/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175205055 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $155.8310/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251047770 CMS
E.R. Squibb & Sons, L.L.C. $146.0410/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184382532 CMS
LEO Pharma Inc. $31.7610/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035098 CMS
LEO Pharma Inc. $2,138.0010/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035100 CMS
LEO Pharma Inc. $54.9210/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252035102 CMS
LEO Pharma Inc. $52.9110/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252035104 CMS
LEO Pharma Inc. $13.8510/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252035106 CMS
Novartis Pharmaceuticals Corporation $41.8110/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200451511 CMS
E.R. Squibb & Sons, L.L.C. $8.8910/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184382540 CMS
LEO Pharma Inc. $124.9910/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035094 CMS
LEO Pharma Inc. $942.2410/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252035096 CMS
Novartis Pharmaceuticals Corporation $26.8910/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200451515 CMS
Galderma Laboratories, L.P. $121.3710/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234701267 CMS
LEO Pharma Inc. $10.6710/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035090 CMS
LEO Pharma Inc. $2,138.0010/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035092 CMS
PFIZER INC. $5.0110/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230944221 CMS
UCB, Inc. $10.1110/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224774134 CMS
ABBVIE INC. $12.9510/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204194380 CMS
LEO Pharma Inc. $15.9610/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035088 CMS
Janssen Biotech, Inc. $8.4610/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175204465 CMS
Lilly USA, LLC $7.9910/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186811815 CMS
Janssen Biotech, Inc. $8.0910/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175204649 CMS
ABBVIE INC. $5.4510/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204194373 CMS
Galderma Laboratories, L.P. $22.3110/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234701265 CMS
LEO Pharma Inc. $2,138.0010/09/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1252035086 CMS
Novartis Pharmaceuticals Corporation $7.7810/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200451505 CMS
LEO Pharma Inc. $8.8510/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252035084 CMS
E.R. Squibb & Sons, L.L.C. $18.7410/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184382528 CMS
Incyte Corporation $27.6210/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226180462 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $516.95 15
PY2024 $4,011.28 101
PY2025 $54,083.08 200

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $56,431.50 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI PASTEUR INC. $2,106.49 10/31/2025 Non-covered Recipient Entity
Empire Clinical Research
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226109193
Principal investigator 1 Novartis Pharmaceuticals Corporation $345.60 10/08/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH
A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihista No dispute reported 06/30/2026 1190311041
Principal investigator 1 SANOFI PASTEUR INC. $1,750.78 10/02/2025 Non-covered Recipient Entity
Empire Clinical Research
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226109181
Principal investigator 1 SANOFI PASTEUR INC. $1,700.78 10/02/2025 Non-covered Recipient Entity
Empire Clinical Research
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226109188
Principal investigator 1 Eli Lilly and Company $5,000.00 08/08/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH LLC
OBSERVATION PRIORITY E SHORT - LEBRIKIZUMAB - ATOPIC DERMATITIS No dispute reported 06/30/2026 1187881236
Principal investigator 1 Novartis Pharmaceuticals Corporation $31,527.85 08/01/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH
A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihista No dispute reported 06/30/2026 1190311043
Principal investigator 1 Incyte Corporation $2,000.00 07/10/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo No dispute reported 06/30/2026 1240531570
Principal investigator 1 Incyte Corporation $2,000.00 03/14/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo No dispute reported 06/30/2026 1240531561
Principal investigator 1 Incyte Corporation $10,000.00 03/14/2025 Non-covered Recipient Entity
EMPIRE CLINICAL RESEARCH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo No dispute reported 06/30/2026 1240531565